 vitamin K antagonist
with at least 3-month treatment is the minimum duration.
In certain cases, consideration of the new oral anticoagulants, such as factor IIa or Xa oral inhibitors, may be indicated if the patient is intolerant of warfarin, although the
evidence for these agents is less well documented.533
Last, a recent RCT suggests that low-dose aspirin may
decrease recurrent DVT in those treated initially with 6